Flagship Ventures Fund 2007, L.p. - Net Worth and Insider Trading

Flagship Ventures Fund 2007, L.p. Net Worth

The estimated net worth of Flagship Ventures Fund 2007, L.p. is at least $4 Million dollars as of 2024-04-27. Flagship Ventures Fund 2007, L.p. is the 10% Owner of Seres Therapeutics Inc and owns about 4,727,484 shares of Seres Therapeutics Inc (MCRB) stock worth over $4 Million. Details can be seen in Flagship Ventures Fund 2007, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Flagship Ventures Fund 2007, L.p. has not made any transactions after 2016-05-25 and currently still holds the listed stock(s).

Transaction Summary of Flagship Ventures Fund 2007, L.p.

To

Flagship Ventures Fund 2007, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Flagship Ventures Fund 2007, L.p. owns 10 companies in total, including TransMedics Group Inc (TMDX) , Axcella Health Inc (AXLA) , and Kaleido Biosciences Inc (KLDO) among others .

Click here to see the complete history of Flagship Ventures Fund 2007, L.p.’s form 4 insider trades.

Insider Ownership Summary of Flagship Ventures Fund 2007, L.p.

Ticker Comapny Transaction Date Type of Owner
TMDX TransMedics Group Inc 2019-05-01 10 percent owner
AXLA Axcella Health Inc 2019-05-08 10 percent owner
KLDO Kaleido Biosciences Inc 2019-02-27 10 percent owner
SESN Sesen Bio Inc 2016-09-06 10 percent owner
RNAC Cartesian Therapeutics Inc 2016-06-21 director & 10 percent owner
MCRB Seres Therapeutics Inc 2016-05-25 10 percent owner
BGMD BG Medicine Inc 2015-07-14 10 percent owner
AGIO Agios Pharmaceuticals Inc 2013-07-23 10 percent owner
TTPH Tetraphase Pharmaceuticals Inc 2013-03-25 10 percent owner
CARM CARISMA Therapeutics Inc 2016-09-06 10 percent owner

Flagship Ventures Fund 2007, L.p. Latest Holdings Summary

Flagship Ventures Fund 2007, L.p. currently owns a total of 1 stock. Flagship Ventures Fund 2007, L.p. owns 4,727,484 shares of Seres Therapeutics Inc (MCRB) as of May 25, 2016, with a value of $4 Million.

Latest Holdings of Flagship Ventures Fund 2007, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MCRB Seres Therapeutics Inc 2016-05-25 4,727,484 0.83 3,900,174

Holding Weightings of Flagship Ventures Fund 2007, L.p.


Flagship Ventures Fund 2007, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Flagship Ventures Fund 2007, L.p. has made a total of 0 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years. The most-recent trade in Seres Therapeutics Inc is the sale of 1,000,000 shares on May 25, 2016, which brought Flagship Ventures Fund 2007, L.p. around $28 Million.

Insider Trading History of Flagship Ventures Fund 2007, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Flagship Ventures Fund 2007, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Flagship Ventures Fund 2007, L.p. Ownership Network

Ownership Network List of Flagship Ventures Fund 2007, L.p.

No Data

Ownership Network Relation of Flagship Ventures Fund 2007, L.p.


Flagship Ventures Fund 2007, L.p. Owned Company Details

What does TransMedics Group Inc do?

Who are the key executives at TransMedics Group Inc?

Flagship Ventures Fund 2007, L.p. is the 10 percent owner of TransMedics Group Inc. Other key executives at TransMedics Group Inc include director & President & CEO Waleed H Hassanein , Chief Commercial Officer Tamer I Khayal , and Chief Financial Officer Stephen Gordon .

TransMedics Group Inc (TMDX) Insider Trades Summary

Over the past 18 months, Flagship Ventures Fund 2007, L.p. made no insider transaction in TransMedics Group Inc (TMDX). Other recent insider transactions involving TransMedics Group Inc (TMDX) include a net sale of 171,317 shares made by Tamer I Khayal , a net sale of 178,500 shares made by Waleed H Hassanein , and a net sale of 91,903 shares made by Stephen Gordon .

In summary, during the past 3 months, insiders sold 132,427 shares of TransMedics Group Inc (TMDX) in total and bought 0 shares, with a net sale of 132,427 shares. During the past 18 months, 573,408 shares of TransMedics Group Inc (TMDX) were sold and 2,500 shares were bought by its insiders, resulting in a net sale of 570,908 shares.

TransMedics Group Inc (TMDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TransMedics Group Inc Insider Transactions

No Available Data

Flagship Ventures Fund 2007, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Flagship Ventures Fund 2007, L.p.. You might contact Flagship Ventures Fund 2007, L.p. via mailing address: 55 Cambridge Parkway, 8th Floor, Cambridge Ma 02142.

Discussions on Flagship Ventures Fund 2007, L.p.

No discussions yet.